SRAM
EW icon

Stone Ridge Asset Management’s Edwards Lifesciences EW Stock Holding History

Stone Ridge Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-15,960
Closed -$1M – 653
2020
Q1 		$1M Sell
15,960
-9,300
-37% -$671K 0.11% 200
2019
Q4 		$1.96M Buy
25,260
+2,100
+9% +$164K 0.12% 207
2019
Q3 		$1.7M Buy
23,160
+3,900
+20% +$274K 0.1% 244
2019
Q2 		$1.19M Buy
19,260
+3,300
+21% +$200K 0.07% 351
2019
Q1 		$1.02M Hold
15,960
– – 0.06% 427
2018
Q4 		$815K Hold
15,960
– – 0.05% 519
2018
Q3 		$926K Hold
15,960
– – 0.05% 531
2018
Q2 		$774K Buy
15,960
+180
+1% +$8.4K 0.04% 560
2018
Q1 		$734K Buy
15,780
+2,100
+15% +$91.2K 0.04% 549
2017
Q4 		$514K Buy
+13,680
New +$502K 0.03% 796

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Stone Ridge Asset Management's EW Position: Q2 2020 in Review

Stone Ridge Asset Management sold out of Edwards Lifesciences (EW) in Q2 2020, closing a stake of 15,960 shares — an estimated $1M sold.

Stone Ridge Asset Management first reported a position in EW in Q4 2017 and held it in 10 quarters. The position peaked at $1.96M in Q4 2019. 1,047 funds tracked by Wall St. Rank hold EW as of Q2 2020.

  • Stone Ridge Asset Management reported no remaining Edwards Lifesciences position as of Q2 2020 after selling out during the quarter.
  • Stone Ridge Asset Management sold 15,960 Edwards Lifesciences shares in Q2 2020, an estimated $1M.
  • Stone Ridge Asset Management first reported a position in Edwards Lifesciences in Q4 2017 and held it in 10 quarters.
  • Stone Ridge Asset Management's Edwards Lifesciences position peaked at $1.96M in Q4 2019.
  • 1,047 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2020.

Based on Stone Ridge Asset Management's 13F filing for Q2 2020, filed 23 Jul 2020.